Cost-effectiveness of screening for detection of small hepatocellular carcinoma in Western patients with Child-Pugh class A cirrhosis

American Journal of Medicine

Volumn 101, Issue 4, 1996, Pages 422-434

  Sarasin, François P ^a,b   Giostra, Emiliano ^a   Hadengue, Antoine ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b Clinique de Medecine 2   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE CLASSIFICATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MEDICAL DECISION MAKING; PATIENT SELECTION; PRIORITY JOURNAL;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; PROGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 0030272405     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00197-0     Document Type: Article

References (64)

1. 1. Sherlock S. Hepatic tumors. In: Sherlock S, Dooley J, eds. Diseases of the Liver and the Biliary System. 9th ed. Oxford: Blackwell Scientific Publications; 1993;503-532.
2. 2. Bismuth H, Houssin D, Ornowski J, Meriggi F. Liver resections in cirrhotic patients: a Western experience. World J Surg. 1986;10:311-317.
3. 3. Pateron D, Ganne N, Trinchet JC, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol. 1994;20:65-71.
4. 4. Tremolda F, Benevegnù L, Drago C, et al. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy. Hepato-gastroenterology. 1989;36:519-521.
5. 5. Imberti D, Fornari F, Sbolli G, et al. Hepatocellular carcinoma in liver cirrhosis. A prospective study. Scand J Gastroenterol. 1993;28:540-544.
6. 6. Cottone M, Turri M, Caltagirone M, et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. J Hepatol. 1994;21:1029-1034.
7. 7. Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. NEJM. 1991;325:675-680.
8. 8. Consensus Report: early diagnosis of hepatocellular carcinoma in Italy. J Hepatol. 1992;14:401-403.
9. 9. London WT, McMahon BJ. Summary of a workshop on screening for hepatocellular carcinoma. MMWR. 1990;39:619-621.
10. 10. Pauker SG, Kassirer JP. Decision analysis. NEJM. 1987;316:250-258.
11. 11. Sonnenberg FA, Pauker SG, Kassirer JP. Decision Maker 7.0. Boston, Mass: Pratt Medical Group; 1991.
12. 12. Beck JR, Pauker SG. The Markov model in medical prognosis. Med Dec Making. 1983;12:419-458.
13. 13. Kassirer JP, Moskowitz AJ, Lau J, Pauker SG. Decision analysis: a progress report. Ann Intern Med. 1987;106:275-291.
14. 14. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Dec Making. 1993;13:322-338.
15. 15. Siegel JE, Kroiewski AS, Warram JH, Weinstein MH. Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus. J Am Soc Nephrol. 1992;3:S111-S119.
16. 16. Krahn MD, Mahoney JE, Eckman MH, et al. Screening for prostate cancer: a decision analytic view. JAMA. 1994;272:773-780.
17. 17. Sarasin FP, Wong JB, Levey AS, Meyer KB. Screening for acquired cystic kidney disease: a decision analytic perspective. Kidney Int. 1995;48:207-219.
18. 18. Schapira MM, Matchar DB, Young MJ. The effectiveness of ovarian cancer screening: a decision analysis model. Ann Intern Med. 1993;118:838-843.
19. 19. Belgheti J. Resection of hepatocellular carcinoma complicating cirrhosis. Br J Surg. 1991;78:257-258.
20. 20. Franco D, Capussoti L, Smadja C, et al. Resection of hepatocellular carcinomas: results in 72 European patients with cirrhosis. Gastroenterology. 1990;98:733-737.
21. 21. Pitre J, Houssin D, Kracht M. Réséction des carcinomes hépatocellulaires: analyse des facteurs pronostiques d'une série multicentrique de 153 malades. Gastroenterol Clin Biol. 1993;17:200-206.
22. 22. Gozzetti G, Mazziotti A, Grazi GL, et al. Surgical experience with 168 primary liver cell carcinomas treated with hepatic resection. J Surg Oncol. 1993;3:S59-S61.
23. 23. Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg. 1994;219:236-247.
24. 24. McPeake J, Williams R. Liver transplantation for hepatocellular carcinoma. Gut. 1995;36:644-646.
25. 25. Moreno P, Jaurrieta E, Figueras J, et al. Orthotopic liver transplantation: treatment of choice in cirrhotic patients with hepatocellular carcinoma? Transpl Proc. 1995;27:2296-2298.
26. 26. Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis. Ann Intern Med. 1990;113:147-154.
27. 27. National Center for Health Statistics. Vital Statistics of the United States, 1989. Vol II. Mortality, part A. DHHS Pub. No (PHS) 90-1101, Public Health Service. Washington DC: US Government Printing Office, 1990.
28. 28. Beck JR, Pauker SG, Gottlieb JE, et al. A convenient approximation of life expectancy: the "DEALE". Use in medical decision making. Am J Med. 1982;73:889-897.
29. 29. Pagliaro L, d'Amico G, Pasta L, et al. Portal hypertension in cirrhosis: natural history. In: Bosch J, Groszman RJ, eds. Portal Hypertension: Pathophysiology and Treatment. 1st ed. Oxford: Blackwell Scientific Publications; 1994:72-93.
30. 30. d'Amico G, Morabito A, Pagliaro L, Marubini E, and the Liver Study Group of "V. Cervello" Hospital. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986:31:468-475.
31. 31. Schlichting P, Christensen E, Andersen PK, et al. and the Copenhagen Study Group for Liver Diseases. Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology. 1983;3:889-895.
32. 32. Christensen E, Schlichting P, Fauerholdt L, et al. and the Copenhagen Study Group for Liver Diseases, Prognostic value of Child-Turcotte Criteria in medically treated cirrhosis. Hepatology. 1984;4:430-435.
33. 33. Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:122-128.
34. 34. Realdi G, Fattovich G, Hadziyannis S, et al. and the EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. J Hepatol. 1994;21:656-666.
35. 35. Fattovich G, Giustina G, Schalm SW, et al. and the EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type B. Hepatology. 1995;21:77-82.
36. 36. Sheu JC, Sung JL, Chen DS, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology. 1983;89: 259-266.
37. 37. Cottone M, Virdone R, Fusco G, et al. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. Gastroenterology, 1989;96:1566-1571.
38. 38. Barbara L, Benzi G, Gaiani S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology, 1992;16:132-137.
39. 39. Kinami Y, Takashima S, Miyazaki I. Hepatic resections for hepatocellular carcinoma associated with liver cirrhosis. World J Surg. 1986;10:294-301.
40. 40. Tang ZY, Yu YQ, Zhou XD, et al. Subclinical hepatocellular carcinoma: an analysis of 391 patients. J Surg Oncol. 1993;3:S55-S58.
41. 41. Bismuth H, Chiche L, Adam R, et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993;218:145-151.
42. 42. Belguiti J, Panis Y, Farges O, et al. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1991;214:114-117.
43. 43. Belli L, Romani F, Belli LS, et al. Reappraisal of surgical treatment of small hepatocellular carcinomas in cirrhosis: clinicopathological study of resection or transplantation. Dig Dis Sci. 1989;34:1571-1575.
44. 44. Calvet X, Bruix J, Gines P, et al. Prognostic factors of hepatocellular carcinoma in the West: a multivariate analysis of 206 patients. Hepatology, 1990;12:753-760.
45. 45. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. NEJM. 1995;332:1256-1261.
46. 46. Regan LS. Screening for hepatocellular carcinoma in high-risk individuals: a clinical review. Arch Intern Med. 1989;149:1741-1744.
47. 47. Maringhini A, Cottone M, Sciarrino E, et al. Ultrasonography and alphafetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis. Dig Dis Sci. 1988;33:47-51.
48. 48. De Santis M, Romagnoli R, Cristani A, et al. MRI of small hepatocellular carcinoma: comparison with US, CT, DSA, and Lipiodol-CT. J Comput Assist Tomogr. 1992;16:189-197.
49. 49. Takayasu K, Moriyama N, Muramatsu Y, et al. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. AJR. 1990;155:49-54.
50. 50. Dodd GD III, Miller WJ, Baron RL, et al. Detection of malignant tumors in end-stage cirrhotic livers: efficacy of sonography as a screening technique. AJR. 1992;159:727-733.
51. 51. Eddy DM. Screening for breast cancer. In: Eddy DM, ed. Common Screening Tests. Philadelphia: American College of Physicians; 1991:229-254.
52. 52. Eddy DM. Screening for cervical cancer. Ann Int Med. 1990;113:214-226.
53. 53. Eddy DM. Screening for colorectal cancer. Ann Int Med. 1990;113:373-384.
54. 54. Pauker SG. Deciding about screening. Ann Int Med. 1993;118:901-902.
55. 55. Kassirer JP, Pauker SG. The "Toss-up". NEJM. 1981;305:1467-1469.
56. 56. Livarighi T, Bolondi L, Buscarini L, et al. and the Italian Cooperative HCC Study Group. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. J Hepatol. 1995;22:522-526.
57. 57. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. NEJM. 1996;334:693-699.
58. 58. Tan KC, Rela M, Ryder SD, et al. Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg. 1995;82:253-256.
59. 59. Vargas V, Castells L, Balsells J, et al. Hepatic resection or orthotopic liver transplant in cirrhotic patients with small hepatocellular carcinoma. Transpl Proc. 1995;27:1243-1244.
60. 60. Pichlmayr R, Weimann A, Oldhafer KJ, et al. Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg. 1995;19:807-813.
61. 61. Selby R, Kadry Z, Carr B, et al. Liver transplantation for hepatocellular carcinoma. World J Surg. 1995;19:53-58.
62. 62. Resmick RH, Koff R. Hepatitis C-related hepatocellular carcinoma: prevalence and Significance. Arch Int Med. 1993;153:1672-1677.
63. 63. Okada S, Shimada K, Yamamoto J, et al. Predictive factors of postoperative recurrence of hepatocellular carcinoma. Gastroenterology. 1994; 106:1618-1624.
64. 64. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston, Toronto: Little, Brown and Co; 1991;153-170.